Indivumed is a biotech company focused on precision oncology. With our unique approach to collecting tissue and data of unmatched quality and variety, we have unlocked a deep understanding of the molecular reality of cancer. This way, we are able to discover novel therapeutic targets that would otherwise be undetectable. Through in-house efforts we can progress small and large molecules toward IND and beyond. With more than 20 years of innovation, we remain true to our vision: a world where precision oncology offers a cure for every cancer patient. To learn more about our mission, visit www.indivumed.com.
Imprint: https://www.indivumed.com/imprint
Privacy Policy Social Media: https://www.indivumed.com/data-protection-policy-social-media/
Company Details
- Employees
- 95
- Founded
- -
- Address
- Falkenried 88, Bldg D, Hamburg,20251,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.indivumed.com/
- Keywords
- Biobanking, Tumor Profiling, Target Identifcation and Validation, Target Discovery, Multi-Omics, Drug Development, Precision Oncology, Biomathematics and AI.
- HQ
- Hamburg
Indivumed Questions
Indivumed's website is https://www.indivumed.com/
Indivumed's LinkedIn profile is https://de.linkedin.com/company/2002-indivumed
Indivumed has
95 employees.
View email and phone details for 95
employees at Indivumed.
Indivumed's industry is
Biotechnology Research
Indivumed's top competitors are
Richter Biologics,
Accellerate,
Qiagen,
Eppendorf,
Crown Bioscience,
Bioagilytix,
Evotec,
Altona Diagnostics,
Indivumed Services,
Life Science Nord.
Indivumed's categories are Biotechnology Research
Indivumed's founding year is 2002
